Matches in SemOpenAlex for { <https://semopenalex.org/work/W4223531916> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W4223531916 abstract "Abstract PURPOSE: To investigate the frequency, clinical significance, and causes of molecular discordances between tru-cut biopsy and residual tumor in patients with breast cancer who received neoadjuvant chemotherapy (NACTx). METHODS: Estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) statuses; hormone expression levels; Ki-67 index; and tumor grade in tru-cut biopsy before NACTx and in the residual tumor after NACTx were evaluated and compared using the Wilcoxon signed-rank test. RESULTS: The study included 102 women. Histopathologically, approximately 70% of the patients were partially responsive and 30% were unresponsive. The concordance and discordance rates between tru-cut biopsy and residual tumor were 95.1% vs. 4.9% (p = 0.180) for ER, 97.1% vs. 2.9% (p = 0.083) for PR, and 89.2% vs. 10.8% (p = 0.763) for HER2. Following NACTx, 15% of hormone receptor (HR)-negative patients and 5.7% of HER2(−) patients became positive, requiring adjuvant treatment. In particular, 18% of triple-negative patients became HR(+) and 12% became HER2(+). HER2 loss was detected in 40% HER2(+) patients. Ki-67 and PR expression significantly decreased in pathologically responsive patients (p = 0.001 and p = 0.004) and tumor grade increased in pathologically unresponsive patients (p = 0.034). CONCLUSION: NACTx alone cannot explain receptor discordance observed in breast cancers . HER2 loss and decreased PR expression levels are mainly associated with NACTx; whereas the receptor status turning positive, which has clinical significance for adjuvant treatment, is primarily associated with intratumoral heterogeneity. Therefore, immunohistochemical re-staining for biomarkers should be performed in residual tumors." @default.
- W4223531916 created "2022-04-15" @default.
- W4223531916 creator A5023628127 @default.
- W4223531916 creator A5063185489 @default.
- W4223531916 date "2022-04-11" @default.
- W4223531916 modified "2023-09-24" @default.
- W4223531916 title "Molecular biomarker discordances of breast cancer before and after neoadjuvant chemotherapy: Are they related to neoadjuvant chemotherapy or intratumoral heterogeneity and is there any clinical significance?" @default.
- W4223531916 doi "https://doi.org/10.21203/rs.3.rs-1515575/v1" @default.
- W4223531916 hasPublicationYear "2022" @default.
- W4223531916 type Work @default.
- W4223531916 citedByCount "0" @default.
- W4223531916 crossrefType "posted-content" @default.
- W4223531916 hasAuthorship W4223531916A5023628127 @default.
- W4223531916 hasAuthorship W4223531916A5063185489 @default.
- W4223531916 hasBestOaLocation W42235319161 @default.
- W4223531916 hasConcept C121608353 @default.
- W4223531916 hasConcept C126322002 @default.
- W4223531916 hasConcept C143998085 @default.
- W4223531916 hasConcept C160798450 @default.
- W4223531916 hasConcept C204232928 @default.
- W4223531916 hasConcept C23589133 @default.
- W4223531916 hasConcept C2775934546 @default.
- W4223531916 hasConcept C2776694085 @default.
- W4223531916 hasConcept C2777982462 @default.
- W4223531916 hasConcept C2778292576 @default.
- W4223531916 hasConcept C2778311097 @default.
- W4223531916 hasConcept C2781197716 @default.
- W4223531916 hasConcept C530470458 @default.
- W4223531916 hasConcept C55493867 @default.
- W4223531916 hasConcept C63363279 @default.
- W4223531916 hasConcept C71924100 @default.
- W4223531916 hasConcept C84606932 @default.
- W4223531916 hasConcept C86803240 @default.
- W4223531916 hasConcept C98717036 @default.
- W4223531916 hasConceptScore W4223531916C121608353 @default.
- W4223531916 hasConceptScore W4223531916C126322002 @default.
- W4223531916 hasConceptScore W4223531916C143998085 @default.
- W4223531916 hasConceptScore W4223531916C160798450 @default.
- W4223531916 hasConceptScore W4223531916C204232928 @default.
- W4223531916 hasConceptScore W4223531916C23589133 @default.
- W4223531916 hasConceptScore W4223531916C2775934546 @default.
- W4223531916 hasConceptScore W4223531916C2776694085 @default.
- W4223531916 hasConceptScore W4223531916C2777982462 @default.
- W4223531916 hasConceptScore W4223531916C2778292576 @default.
- W4223531916 hasConceptScore W4223531916C2778311097 @default.
- W4223531916 hasConceptScore W4223531916C2781197716 @default.
- W4223531916 hasConceptScore W4223531916C530470458 @default.
- W4223531916 hasConceptScore W4223531916C55493867 @default.
- W4223531916 hasConceptScore W4223531916C63363279 @default.
- W4223531916 hasConceptScore W4223531916C71924100 @default.
- W4223531916 hasConceptScore W4223531916C84606932 @default.
- W4223531916 hasConceptScore W4223531916C86803240 @default.
- W4223531916 hasConceptScore W4223531916C98717036 @default.
- W4223531916 hasLocation W42235319161 @default.
- W4223531916 hasOpenAccess W4223531916 @default.
- W4223531916 hasPrimaryLocation W42235319161 @default.
- W4223531916 hasRelatedWork W11917847 @default.
- W4223531916 hasRelatedWork W14057612 @default.
- W4223531916 hasRelatedWork W14222361 @default.
- W4223531916 hasRelatedWork W3918396 @default.
- W4223531916 hasRelatedWork W5094028 @default.
- W4223531916 hasRelatedWork W5347361 @default.
- W4223531916 hasRelatedWork W692822 @default.
- W4223531916 hasRelatedWork W8724660 @default.
- W4223531916 hasRelatedWork W8962657 @default.
- W4223531916 hasRelatedWork W13191403 @default.
- W4223531916 isParatext "false" @default.
- W4223531916 isRetracted "false" @default.
- W4223531916 workType "article" @default.